DWS CROCI Equity Dividend Fund C (KDHCX)
58.70
-0.26
(-0.44%)
USD |
Nov 18 2026
Key Stats
| Net Expense Ratio | Total Assets Under Management | Weighted Average Dividend Yield | Turnover Ratio (Generic) |
|---|---|---|---|
| 1.81% | 849.38M | 3.22% | 100.0% |
| 1 Year Fund Level Flows | 1 Year Total Returns (Daily) | Annualized Total Returns Since Inception (Daily) | Max Drawdown (Since Inception) |
| -118.80M | 28.42% |
Basic Info
| Investment Strategy | |
| The Fund seeks to invest at least 80% of net asset in equity securities (mainly common stocks). The Fund focuses on stocks of large US companies that are similar in size to the companies in the S&P 500 Index and that portfolio management believes are undervalued. |
| General | |
| Security Type | Mutual Fund |
| Equity Style | Multi Cap Value |
| Broad Asset Class | US Equity |
| Broad Category | Equity |
| Global Peer Group | Equity US |
| Peer Group | Multi-Cap Value Funds |
| Global Macro | Equity North America |
| US Macro | Multi-Cap Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | -- |
| Fund Owner Firm Name | DWS |
| Broad Asset Class Benchmark Index | |
| ^SPXTR | 100.0% |
Fund Flows
Risk
Performance Versus Peer Group
Annual Total Returns Versus Peers
As of November 19, 2026.
Asset Allocation
As of September 30, 2026.
| Type | % Net |
|---|---|
| Cash | 0.00% |
| Stock | 99.46% |
| Bond | 0.00% |
| Convertible | 0.00% |
| Preferred | 0.00% |
| Other | 0.54% |
Top 10 Holdings
| Name | % Weight | Price | % Change |
|---|---|---|---|
| Cognizant Technology Solutions Corp. | 3.25% | 56.32 | -2.81% |
| HP, Inc. | 3.21% | 27.84 | -2.88% |
| Accenture Plc | 3.20% | 218.56 | -3.93% |
| Merck & Co., Inc. | 2.86% | 132.82 | -3.60% |
| Amgen, Inc. | 2.86% | 439.06 | -1.09% |
| Skyworks Solutions, Inc. | 2.84% | 78.68 | -4.55% |
| Pfizer Inc. | 2.84% | 27.58 | -1.71% |
| Gilead Sciences, Inc. | 2.78% | 166.58 | -1.42% |
| Amdocs Ltd. | 2.71% | 40.52 | -4.16% |
| Hasbro, Inc. | 2.64% | 114.72 | -3.30% |
Fees & Availability
| Fees | |
| Actual 12B-1 Fee | 0.98% |
| Actual Management Fee | 0.56% |
| Administration Fee | -- |
| Maximum Front Load | 0.00% |
| Maximum Deferred Load | 1.00% |
| Maximum Redemption Fee | 0.00% |
| General Availability | |
| Available for Insurance Product | No |
| Available for RRSP | No |
| Purchase Details | |
| Open to New Investors |
|
| Minimum Initial Investment | 1000.00 None |
| Minimum Subsequent Investment | 50.00 None |
TTM Distributions
| Type | Nov | Dec | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Qualified Income
|
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
|
Normal
|
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
|
Qualified
|
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
|
LT Cap Gains
|
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
|
Ordinary Income
|
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
|
Non-Qual
|
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
|
ST Cap Gains
|
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
|
Interest
|
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
|
Tax-Exempt
|
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
|
ROC
|
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
|
Other
|
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
|
Total
|
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
As of October 31, 2026.
Basic Info
| Investment Strategy | |
| The Fund seeks to invest at least 80% of net asset in equity securities (mainly common stocks). The Fund focuses on stocks of large US companies that are similar in size to the companies in the S&P 500 Index and that portfolio management believes are undervalued. |
| General | |
| Security Type | Mutual Fund |
| Equity Style | Multi Cap Value |
| Broad Asset Class | US Equity |
| Broad Category | Equity |
| Global Peer Group | Equity US |
| Peer Group | Multi-Cap Value Funds |
| Global Macro | Equity North America |
| US Macro | Multi-Cap Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | -- |
| Fund Owner Firm Name | DWS |
| Broad Asset Class Benchmark Index | |
| ^SPXTR | 100.0% |
Fundamentals
| General | |
| Distribution Yield | -- |
| Dividend Yield TTM (11-18-26) | 2.82% |
| 30-Day SEC Yield (10-31-26) | 1.33% |
| 7-Day SEC Yield | -- |
| Number of Holdings | 45 |
| Stock | |
| Weighted Average PE Ratio | 21.14 |
| Weighted Average Price to Sales Ratio | 2.791 |
| Weighted Average Price to Book Ratio | 5.550 |
| Weighted Median ROE | 27.29% |
| Weighted Median ROA | 6.27% |
| Return on Investment (TTM) | 10.47% |
| Earning Yield | 0.0608 |
| LT Debt / Shareholders Equity | 1.379 |
| Number of Equity Holdings | 43 |
As of September 30, 2026
Growth Metrics
| EPS Growth (1Y) | 12.03% |
| EPS Growth (3Y) | 2.65% |
| EPS Growth (5Y) | 12.21% |
| Sales Growth (1Y) | 6.39% |
| Sales Growth (3Y) | 3.55% |
| Sales Growth (5Y) | 8.21% |
| Sales per Share Growth (1Y) | 6.73% |
| Sales per Share Growth (3Y) | 4.38% |
| Operating Cash Flow - Growth Rate (3Y) | 9.95% |
As of September 30, 2026
Fund Details
Top Portfolio Holders
| Name | % Weight |
|---|---|
| Portfolio A | 5.00% |
| Portfolio B | 3.50% |
| Portfolio C | 2.25% |
Excel Add-In Codes
| Name: =YCI("M:KDHCX", "name") |
| Broad Asset Class: =YCI("M:KDHCX", "broad_asset_class") |
| Broad Category: =YCI("M:KDHCX", "broad_category_group") |
| Prospectus Objective: =YCI("M:KDHCX", "prospectus_objective") |
| To find the codes for any of our securities and financial metrics, see our Complete Excel Reference. |